Northern Trust’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Northern Trust’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-57,235	Closed	-$20K	–	4400
2018 Q2	$20K	Buy	57,235 +300	+0.5%	+$246	﹤0.01%	4218
2018 Q1	$86K	Buy	56,935 +329	+0.6%	+$574	﹤0.01%	4004
2017 Q4	$81K	Buy	56,606 +4,174	+8%	+$6.85K	﹤0.01%	4010
2017 Q3	$120K	Sell	52,432 -6,583	-11%	-$8.81K	﹤0.01%	3913
2017 Q2	$79K	Buy	59,015 +6,616	+13%	+$9.56K	﹤0.01%	4018
2017 Q1	$112K	Sell	52,399 -12,393	-19%	-$46.6K	﹤0.01%	3932
2016 Q4	$286K	Buy	64,792 +1,535	+2%	+$7.29K	﹤0.01%	3666
2016 Q3	$307K	Buy	63,257 +3,091	+5%	+$14.1K	﹤0.01%	3622
2016 Q2	$199K	Sell	60,166 -485,604	-89%	-$1.83M	﹤0.01%	3730
2016 Q1	$1.94M	Buy	+545,770	New	+$2.81M	﹤0.01%	3005

Other funds holding ARLZ

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Northern Trust's ARLZ Position: Q3 2018 in Review

Northern Trust sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 57,235 shares — an estimated $20K sold.

Northern Trust first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1.94M in Q1 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

Northern Trust reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
Northern Trust sold 57,235 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $20K.
Northern Trust first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
Northern Trust's Aralez Pharmaceuticals Inc. position peaked at $1.94M in Q1 2016.
4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Northern Trust's 13F filing for Q3 2018, filed 14 Nov 2018.